Home Blog Page 121

Blog

Pharma Marketing Blog

Most popular

“Play by the Rules”: Analysis of Ground Rules for 4HER Patient...

Pharma Guy - October 9, 2014

EU to Release Data in December That Could Put Alli Diet...

Pharma Guy - November 19, 2010

My Man in Milan

Pharma Guy - December 6, 2013

Quantified Self-focused Narcissism

Pharma Guy - March 12, 2013

More Pharma Social Media Pioneers Recognized

Pharma Guy - February 24, 2011

Cialis Blog Shut Down

Pharma Guy - February 8, 2006

Yahoo!’s Claim That Patients Are “Ambivalent” When It Comes to Side...

Pharma Guy - March 16, 2010

FDA’s Abrams Spends 4 Minutes Discussing Social Media Guidance at ePharma...

Pharma Guy - February 10, 2011

The Merck and Vioxx Show

Pharma Guy - November 9, 2007

Is FDA Too Slow to Approve New Drugs?

Pharma Guy - July 5, 2017

1...120121122...240 Page 121 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026